The SLC34A1 gene helps the kidneys take phosphate back into the body instead of losing it in urine. This gene plays an important role in keeping bones and teeth strong and in balancing minerals such as calcium and phosphate. If it does not work properly, some people lose too much phosphate, which can lead to kidney stones, calcium buildup in the kidneys, weak bones, or slow growth in childhood. Certain pathogenic variants in the SLC34A1 gene are linked to inherited kidney and mineral balance conditions.
What is a gene?
Genes are sections of DNA that give your cells instructions they can use to make molecules or regulate activities in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Other genes are mainly involved in controlling when certain activities happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
SLC34A1Gene function
What if the gene works
The SLC34A1 gene helps the kidneys move phosphate back into the blood instead of losing it in urine. This supports healthy phosphate levels for bones, teeth, and normal energy use.
Risk
What if the gene does not work
Variants in the SLC34A1 gene can disrupt kidney phosphate handling, causing kidney stones, calcium buildup in the kidneys, or high calcium in infants. Milder and more severe variants may change when symptoms start and how pronounced they are.
Treatment
What does that mean for your treatment
No SLC34A1-specific treatment or management approach is currently established. Care is guided by the person’s calcium, phosphate, and kidney findings rather than by a gene-targeted drug.
Conditions associated with SLC34A1
Gene function
What if the gene works
In your kidneys, a transport protein made from the SLC34A1 gene helps reclaim phosphate before it leaves the body in urine. This steady recycling supports mineral balance every day. Understanding what the SLC34A1 gene does helps explain how your body keeps enough phosphate for bones, teeth, and many basic cell tasks.
In the kidney's filtering tubes, the SLC34A1 gene helps move phosphate back into the body. It uses sodium as a partner to carry phosphate through kidney cells, so the body can keep this important mineral.
By reclaiming phosphate, this gene helps keep phosphate levels steady in the blood. That steady supply supports normal day to day mineral balance, including the needs of bones and teeth.
Phosphate is needed to make ATP (the cell's main energy source) and other basic cell building blocks. By helping the body hold on to phosphate, this gene supports many routine cell activities.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and help explain normal human diversity, such as variations in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC34A1 gene can change the shape, stability, or cell-surface placement of its phosphate transporter, which shows how variants in the SLC34A1 gene affect phosphate transport. Some variants leave a partly working protein with reduced activity, while more severe variants can keep the transporter from reaching the cell membrane or make it break down early. This spectrum from milder to more disruptive variants can influence how much function is lost.
How variants are linked to conditions
Pathogenic variants in the SLC34A1 gene are best known for causing infantile hypercalcemia type 2, so the SLC34A1 gene and infantile hypercalcemia are a well-established link in medical genetics. This condition often includes high calcium levels in infancy, and many affected children also have kidney stones or calcium buildup in the kidneys. Some people with SLC34A1-related disease later develop low phosphate levels and bone symptoms such as bone pain or softer bones.
A variant is not necessarily a diagnosis
Genetic variants are a natural part of human biology and are common across the general population. Most do not have a direct impact on health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risks related to the SLC34A1 gene. Risk can vary depending on the exact gene change and whether someone has one or two changed copies, so personal guidance from a doctor or genetic counselor can be helpful.
Inheritance of SLC34A1 variants
For the SLC34A1 gene, the inheritance pattern can differ depending on the condition linked to the variant. Some SLC34A1-related conditions follow an autosomal recessive pattern, which means a child inherits one altered copy from each parent, while others are reported with autosomal dominant inheritance, where one altered copy from either parent can be enough to be linked to disease. In families asking about the SLC34A1 inheritance pattern, this means the chance of passing it on depends on the exact condition and the specific variant involved.
What does my SLC34A1 result mean for my family?
SLC34A1 results can have different family implications because this gene is linked to more than one inherited condition. In some families, parents may each carry a changed copy without having symptoms, so brothers, sisters, or future children could also be affected or be carriers. In others, a changed copy can run through several generations, so close relatives may also have the same result. What it means for your family depends on the exact SLC34A1 change and the condition involved.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SLC34A1 gene, genetic testing for SLC34A1 variants uses a blood or saliva sample and reads the DNA code in a lab. It can identify specific variants, and the results are interpreted alongside your symptoms, kidney findings, and family history.
When should I consider getting a genetic test?
Genetic testing for the SLC34A1 gene may be considered if a baby or child has unexplained high calcium levels, calcium buildup in the kidneys, or repeated kidney stones, especially along with low phosphate levels. It can also be helpful when these problems seem to run in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, moves, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how likely they are to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It studies gene-drug patterns to help explain why the same treatment may work differently in different people. For many drugs, genes influence how strongly a medicine works or how the body handles it. This information can support more informed, personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC34A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines, so questions about side effects, new symptoms, or medication choices are best discussed with your doctor.
History
Research on kidney phosphate handling set the stage for the discovery of the SLC34A1 gene in the 1990s, when scientists were identifying the transport proteins that move phosphate back into the body. Initially understood only through visible traits, later recognized as tied to a specific gene, this work connected earlier physiology studies with human genetics. Building on this early work, scientists linked variants in the SLC34A1 gene to inherited forms of kidney stones, calcium deposits in the kidneys, and changes in phosphate balance. That shift helped move the field from describing symptoms to finding an underlying genetic cause. Over time, descriptions became more precise as testing improved and more families were studied. These historical steps shaped today’s understanding of SLC34A1-related kidney conditions.